Skip to main content
    O

    Omnicell Inc (OMCL)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ

    $35.95
    +0.56 (+1.58%)

    Market Cap: $1.64B

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    90%(35/39)
    Avg Surprise
    +58.30%
    Streak
    2 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$0.42
    Range$0.35 - $0.53
    8 analysts
    EPS Revisions
    1
    0
    7d
    1
    5
    30d
    EPS Estimate DriftChange to current
    90d ago$0.47-10.9%
    60d ago$0.47-10.9%
    30d ago$0.420.0%
    7d ago$0.420.0%
    Current$0.42
    Revenue Consensus
    $304M
    Range$302M - $306M
    8 analysts
    Period ending Dec 31, 2026
    EPS Consensus$1.05
    Range$0.80 - $1.27
    8 analysts
    Revenue Consensus
    $318M
    Range$310M - $326M
    8 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$1.05---
    Sep 26EST
    		-$0.42---
    Jun 26
    Reported Jul 30
    		$0.70$0.31+125.81%Beat+55.6%
    Mar 26
    Reported Apr 28
    		$0.55$0.33+66.67%Beat+111.5%
    Dec 25
    Reported Feb 5
    		$0.40$0.50-20.00%Miss-33.3%
    Sep 25
    Reported Oct 30
    		$0.51$0.36+41.67%Beat-8.9%
    Jun 25
    Reported Jul 31
    		$0.45$0.27+66.67%Beat-11.8%
    Mar 25
    Reported May 6
    		$0.26$0.20+30.00%Beat+766.7%
    Dec 24
    Reported Feb 6
    		$0.60$0.58+3.45%Beat+81.8%
    Sep 24
    Reported Oct 30
    		$0.56$0.42+33.33%Beat-9.7%
    Jun 24
    Reported Aug 1
    		$0.51$0.14+264.29%Beat-10.5%
    Mar 24
    Reported May 2
    		$0.03N/A+133.33%Beat-92.3%
    Dec 23
    Reported Feb 8
    		$0.33$0.15+120.00%Beat+0.0%
    Sep 23
    Reported Nov 2
    		$0.62$0.48+29.17%Beat-38.0%
    Jun 23
    Reported Aug 1
    		$0.57$0.28+103.57%Beat-32.1%
    Mar 23
    Reported May 2
    		$0.39$0.07+457.14%Beat-53.0%
    Dec 22
    Reported Feb 28
    		$0.33$0.09+266.67%Beat-64.1%
    Sep 22
    Reported Nov 2
    		$1.00$0.95+5.26%Beat-7.4%
    Jun 22
    Reported Aug 4
    		$0.84$0.85-1.18%Miss-13.4%
    Mar 22
    Reported Apr 28
    		$0.83$0.68+22.06%Beat+0.0%
    Dec 21
    Reported Feb 14
    		$0.92$0.92+0.00%Beat+1.1%
    Sep 21
    Reported Nov 2
    		$1.08$0.91+18.68%Beat+80.0%
    Jun 21
    Reported Jul 29
    		$0.97$0.83+16.87%Beat+162.2%
    Mar 21
    Reported Apr 29
    		$0.83$0.66+25.76%Beat+25.8%
    Dec 20
    Reported Feb 1
    		$0.91$0.82+10.98%Beat+18.2%
    Sep 20
    Reported Oct 27
    		$0.60$0.49+22.45%Beat-21.1%
    Jun 20
    Reported Jul 28
    		$0.37$0.23+60.87%Beat-44.8%
    Mar 20
    Reported May 7
    		$0.66$0.51+29.41%Beat+8.2%
    Dec 19
    Reported Feb 6
    		$0.77$0.78-1.28%Miss+10.0%
    Sep 19
    Reported Oct 24
    		$0.76$0.71+7.04%Beat+20.6%
    Jun 19
    Reported Jul 25
    		$0.67$0.63+6.35%Beat+45.7%
    Mar 19
    Reported Apr 25
    		$0.61$0.41+48.78%Beat+110.3%
    Dec 18
    Reported Feb 7
    		$0.70$0.67+4.48%Beat+29.6%
    Sep 18
    Reported Oct 25
    		$0.63$0.56+12.50%Beat+50.0%
    Jun 18
    Reported Jul 26
    		$0.46$0.39+17.95%Beat+48.4%
    Mar 18
    Reported Apr 26
    		$0.29$0.25+16.00%Beat+383.3%
    Dec 17
    Reported Feb 1
    		$0.54$0.52+3.85%Beat+45.9%
    Sep 17
    Reported Oct 26
    		$0.42$0.42+0.00%Beat-
    Jun 17
    Reported Jul 27
    		$0.31$0.23+34.78%Beat-
    Mar 17
    Reported May 4
    		$0.06$0.02+200.00%Beat-
    Dec 16
    Reported Feb 15
    		$0.37$0.41-9.76%Miss-

    Key Metrics

    Valuation
    P/E Ratio16.64EV/EBITDA10.26x
    Price/FCF11.50xFCF Yield8.70%
    Profitability
    Profit Margin3.14%Operating Margin5.91%
    ROE3.06%ROIC2.72%
    Financial Health
    Debt/Equity0.13xInterest CoverageN/A
    Current Ratio1.64xQuick Ratio1.43x
    Trading Statistics
    Beta0.99Avg Volume489.79K
    52-Week High$55.0052-Week Low$29.09

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$35.42
    SMA 20$34.37
    SMA 50$34.63
    SMA 200$39.69
    EMA 10$35.43
    EMA 20$34.89
    EMA 50$35.44
    EMA 200$37.56

    MACD

    Line: 0.45Signal: 0.14Hist: 0.31

    ADX

    ADX: 22.5+DI: 26.3-DI: 16.4

    Aroon & PSAR

    Aroon Up92.0
    Aroon Down28.0
    PSAR$35.07

    Bollinger Bands

    Upper Band$37.05
    Lower Band$31.69
    %B Position1561%(Upper)
    Band Width0.79

    RSI (14-Day)

    Neutral
    57.2

    Momentum Oscillators

    Stoch %K70.3
    Stoch %D79.3
    Williams %R-29.7
    ROC (10d)7.5%
    Momentum2.51
    CCI (20d)90.5
    MFI (14d)79.7

    Volatility Measures

    ATR (14d)$1.15(3.2%)
    StdDev (20d)1.34
    Hist Vol27.7%(Moderate)

    Volume Flow

    VWAP$35.80
    OBV5.0M
    AD Line-877.4K
    CMF (20d)0.231

    Volume Metrics

    Avg Vol (20d)497.1K
    Vol Ratio0.8x
    VWMA (20d)$34.23

    Pivot Points

    R3$37.52
    R2$36.96
    R1$36.18
    Pivot Point$35.62
    S1$34.84
    S2$34.28
    S3$33.50

    Advanced Oscillators

    TSI11.34
    Ultimate Osc56.9
    KST40.54

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$312.21M$309.88M$313.98M$310.63M$290.56M$269.67M$306.88M$282.42M$276.79M$246.15M$258.85M$298.66M
    Cost of Revenue$159.27M$169.52M$183.66M$176.13M$162.88M$158.73M$165.12M$160.15M$162.44M$153.53M$153.44M$166.70M
    Gross Profit$152.94M$140.36M$130.32M$134.50M$127.68M$110.94M$141.76M$122.27M$114.35M$92.62M$105.40M$131.96M
    Operating Expenses$120.49M$123.51M$129.91M$126.26M$119.56M$122.56M$129.37M$115.70M$111.13M$114.47M$128.77M$128.25M
    R&D$20.30M$21.52M$22.55M$24.02M$21.57M$20.53M$26.04M$21.21M$21.10M$22.06M$26.82M$24.28M
    SG&A$100.19M$101.99M$107.36M$102.24M$97.98M$102.03M$103.33M$94.49M$90.03M$92.41M$101.95M$103.97M
    Operating Income$32.45M$16.85M$415,000$8.24M$8.12M$-11,619,000$12.40M$6.56M$3.22M$-21,847,000$-23,365,000$3.71M
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Income Before Tax$33.83M$16.91M$699,000$9.70M$10.45M$-9,530,000$23.60M$11.63M$8.20M$-17,831,000$-18,517,000$7.38M
    Income Tax Expense$9.54M$5.55M$2.73M$4.24M$4.81M$-2,507,000$7.76M$3.00M$4.46M$-2,155,000$-4,142,000$1.83M
    Net Income$24.29M$11.36M$-2,026,000$5.46M$5.64M$-7,023,000$15.84M$8.63M$3.73M$-15,676,000$-14,375,000$5.55M
    EBITDA$55.08M$37.90M$22.98M$31.76M$32.83M$13.05M$46.68M$34.16M$31.98M$6.32M$6.46M$31.98M
    EBIT$33.83M$16.91M$699,000$9.70M$10.45M$-9,530,000$23.60M$11.63M$8.20M$-17,831,000$-18,517,000$7.38M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about OMCL

    Government Contracts

    Gov Obligations (TTM)
    $46.73M
    Gov Obligations / Revenue
    3.7%
    Obligations YoY
    69.4%
    Active Awards
    271
    New Awards (TTM)
    150
    Avg Remaining Term
    7.0 mo

    Top agency: Department of Veterans Affairs at 93.3% of trailing twelve month obligations across 3 agencies

    Recent Awards

    Award IDAgencyObligatedStart
    36C26026N0051Department of Veterans AffairsDepartment of Veterans Affairs$5.39MOct 28, 2025
    36C26026N0195Department of Veterans AffairsDepartment of Veterans Affairs$4.91MAug 1, 2026
    36C25726P0504Department of Veterans AffairsDepartment of Veterans Affairs$4.04MJun 30, 2026
    36C25025P1730Department of Veterans AffairsDepartment of Veterans Affairs$3.20MSep 25, 2025
    36C24625N1184Department of Veterans AffairsDepartment of Veterans Affairs$1.52MSep 9, 2025
    36C25925P1187Department of Veterans AffairsDepartment of Veterans Affairs$1.27MSep 30, 2025
    W91YTZ25FA185Department of DefenseDepartment of the Army$809751Sep 3, 2025
    36C26326N0468Department of Veterans AffairsDepartment of Veterans Affairs$803711May 1, 2026
    36C26025N0341Department of Veterans AffairsDepartment of Veterans Affairs$698175Sep 3, 2025
    75N98026P00709Department of Health and Human ServicesNational Institutes of Health$697920Jun 15, 2026

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    OMCL Valuation and Fair Value

    P/E
    16.6x
    Forward P/E
    29.5x
    EV/EBITDA
    10.3x
    P/FCF
    11.5x
    PEG
    15.4x
    P/B
    1.3x
    See GNG's fair value

    OMCL Profitability: Margins, ROIC and FCF

    Gross margin
    44.8%
    Operating margin
    5.9%
    Net margin
    3.1%
    ROIC
    2.7%
    ROE
    3.1%
    FCF margin
    11.4%
    FCF yield
    8.7%

    OMCL Competitors

    CompanyTicker
    Nuvation Bio IncNUVB
    Forte Biosciences IncFBRX
    Biohaven Ltd.BHVN
    Zenas BioPharma, Inc. Common StockZBIO
    Azenta IncAZTA
    Kestra Medical Technologies, Ltd. Common StockKMTS
    Novocure LtdNVCR
    Ocular Therapeutix IncOCUL

    Sector: Healthcare

    OMCL Analyst Ratings

    Consensus
    Buy
    Analysts
    8
    Strong Buy
    1
    Buy
    6
    Hold
    1
    Sell
    0
    Strong Sell
    0

    OMCL Bull Case vs Bear Case

    Bull case

    • OMCL beat EPS estimates in 87.5% of its last 8 reported quarters.
    • 87.5% of OMCL's analyst ratings are Buy or Strong Buy.

    OMCL Earnings: Beat Rate and Next Report

    Beat rate
    7 of 8 quarters (87.5%)
    Average surprise
    43.4%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $0.42
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    1 up, 5 down

    Frequently Asked Questions About OMCL

    Does OMCL pay dividends?

    Omnicell Inc (OMCL) does not currently pay a regular dividend.

    What is OMCL's P/E ratio?

    Omnicell Inc has a price-to-earnings (P/E) ratio of 16.64.

    What is OMCL's market cap?

    Omnicell Inc (OMCL) has a market capitalization of $1.64B with a current stock price of $35.95.

    Related stocks

    Sector: Healthcare

    All stocks starting with O

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In